Evidence map›Paper›PMID 37049468›Full record

ArticleNutrients2023

Sesamin Metabolites Suppress the Induction of Cellular Senescence.

Chie Araki, Daisuke Takemoto, Yoshinori Kitagawa, Norifumi Tateishi, Tomohiro Rogi, Takayuki Izumo, Shimpei Kawamoto, Hiroshi Shibata, Eiji Hara, Masaaki Nakai

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chie ArakiInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Daisuke TakemotoInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.ORCID 0000-0003-3465-0581
Yoshinori KitagawaInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Norifumi TateishiInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Tomohiro RogiInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.ORCID 0000-0001-8665-8337
Takayuki IzumoInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Shimpei KawamotoDepartments of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Hiroshi ShibataInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Eiji HaraDepartments of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Masaaki NakaiInstitute for Health Care Science, Suntory Wellness Limited, Kyoto 619-0284, Japan.
Suntory Foundation for Life Sciences · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular senescence induces inflammation and is now considered one of the causes of organismal aging. Accumulating evidence indicates that age-related deterioration of mitochondrial function leads to an increase in reactive oxygen species (ROS) and DNA damage, which in turn causes cellular senescence. Thus, it is important to maintain mitochondrial function and suppress oxidative stress in order to inhibit the accumulation of senescent cells. Sesamin and its isomer episesamin are types of lignans found in sesame oil, and after being metabolized in the liver, their metabolites have been reported to exhibit antioxidant properties. However, their effects on cellular senescence remain unknown. In this study, the effects of sesamin, episesamin, and their metabolites SC1 and EC1-2 on replicative senescence were evaluated using human diploid lung fibroblasts, and TIG-3 cells. The results showed that sesamin and episesamin treatment had no effect on proliferative capacity compared to the untreated late passage group, whereas SC1 and EC1-2 treatment improved proliferative capacity and mitigated DNA damage of TIG-3 cells. Furthermore, other cellular senescence markers, such as senescence-associated secretory phenotype (SASP), mitochondria-derived ROS, and mitochondrial function (ROS/ATP ratio) were also reduced by SC1 and EC1-2 treatment. These results suggest that SC1 and EC1-2 can maintain proper mitochondrial function and suppress the induction of cellular senescence.

Indexed as

LignansLiverCellular SenescenceDioxolesHumansReactive Oxygen SpeciesDioxolesLignansReactive Oxygen Speciessesamincellular senescenceEC1-2episesaminmitochondriaSC1sesamin

Identifiers

PMID37049468
PMCPMC10096530
OpenAlexW4361216153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.